AbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017

Press/Media: Press / Media

PeriodOct 11 2017 → Oct 20 2017

Media coverage

12

Media coverage

  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/20/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/19/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/18/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/17/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/14/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/14/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/14/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/12/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/12/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date10/12/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletBiotechgate
    CountrySwitzerland
    Date10/11/17
    PersonsFred Poordad
  • TitleAbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting® 2017
    Media name/outletUSA Life Sciences Database
    CountrySwitzerland
    Date10/11/17
    PersonsFred Poordad